NEWS RELEASE
March 12, 2021
For Immediate Release
Japan Impact Investment II Limited Partnership

Impact Investment in CureApp, Inc.
Japan Impact Investment II Limited Partnership (hereinafter, "HATARAKU FUND") underwrote thethird-party allotment executed by CureApp, Inc. (Chuo-ku, Tokyo, President and CEO Kohta Satake,"CureApp").
Based on its mission of "re-evolving therapeutics with software," CureApp aims to create newtreatments using technology and resolve social issues surrounding healthcare. CureApp develops anddistributes their digital therapeutic applications with the goal of improving the effectiveness of treatment
for diseases such as addiction and lifestyle-related diseases through a new approach of behavioral
transformation. These diseases are generally considered difficult to treat effectively through conventional
treatment alone. In December 2020, CureApp successfully launched their nicotine addiction treatment,
the first digital therapeutic treatment to obtain regulatory approval in Japan, and the first to receive fullinsurance reimbursement.
HATARAKU FUND is the successor to Japan Impact Investment I Limited Partnership (commonlyknown as the Child-care Support Fund), which was established in January 2017 as the first impact
investment fund operated by a Japanese banking group, and this fund was designed to make impact
investment※1 into the domestic child-care-related business. Jointly managed by Japan Social Innovation
and Investment Foundation and the Shinsei Bank Group, with advisory from Mizuho Bank, Ltd.,HATARAKU Fund has received funding from a large number of institutional investors. We aim to support
the growth of investees’ businesses and expand social impact by investing in businesses related to childcare, elder-care, and new work styles.
HATARAKU FUND has made this impact investment based on the potential of these digital therapeutic
applications and others currently in R&D for further domestic and international growth as a new treatment,
as well as their support for primarily working populations and alignment with HATARAKU FUND’s targetedgoal to enhance diverse work styles and lifestyles. In addition, through the due diligence phase, we havediscussed in-depth with the management team to introduce the "Impact Measurement and Management"※2
process, where CureApp measures and visualizes the social impact from its business and utilizes theresults to improve management processes and business strategies. Going forward, we will continue tosupport the development of CureApp’s social and economic value, while actively promoting theestablishment of the impact investment ecosystem.
*1 Investments aiming to achieve both economic and social returns.
*2 Incorporate social impact measurement into management PDCA cycles and apply them to business management.

■ Summary of CureApp, Inc.
Name
Date established
Representative
Head office::::Business
Description:

CureApp, Inc.
July. 2014
Kohta Satake, President and CEOKodenmacho YS Building 4F, 12-5, Nihonbashi Kodenmacho, Chuo-ku, Tokyo
Program Medical Device Development, Mobile Health Services Business■ Summary of the HATARAKU FUND
Name:

Date established
General partner(GP)::GP Member:

AdvisorFund Period
Investment
Target:::Japan Impact Investment II Limited Partnership(commonly referred to as "HATARAKU FUND")
June 28, 2019Japan Impact Investment II LLP
Shinsei Impact Investment Limited
Japan Social Innovation and Investment Foundation
Mizuho Bank, Ltd.
Investment period of 5 years, fund term of 10 years
Early to later stage companies operating child-care,nursing care, and new work-style-related businessesEnd